Subscribe to Newsletter

Technology and innovation

Inside the Lab Digital and computational pathology

People Power and Machine Learning

| Geoff Twist

A collaboration between industry, academia, and the clinic could lead to more efficient, more personalized cancer diagnosis and treatment

Diagnostics Analytical science

Sensing the Tiniest Change

| Menno Prins

New biomarker sensing technology can detect miniscule concentrations of molecules in the blood to assist with patient monitoring

Diagnostics Genetics and epigenetics

Thinking Outside the (Genome) Box

| Jason Mellad

Epigenetics may combine with liquid biopsy to offer an effective way of detecting early-stage cancers and recurrences

Inside the Lab Clinical care

Biochip Breakthrough

| Luke Turner, Arjang Hassibi

With antimicrobial resistance an ever-increasing threat to modern medicine, a new breakthrough may rapidly identify drug-resistant microbe strains to ensure effective treatment

Inside the Lab Biochemistry and molecular biology

One Drop at a Time

| Alexander Dobrovic and Cloud Paweletz

When seeking the greatest benefit from liquid biopsy, droplet digital PCR can help by offering speed, sensitivity, and absolute quantitation

Inside the Lab Clinical care

From Dream to Deployment

| Sponsored by Leica Biosystems

Leeds Teaching Hospitals NHS Trust and Leica Biosystems have formed a unique partnership to make a 100% digital pathology service a reality

Outside the Lab Profession

Leadership Is an Opportunity and Our Obligation

| E. Blair Holladay

To stay at the forefront of medicine, pathologists and laboratorians need to become drivers for change in our own institutions

Inside the Lab Clinical care

Pathologists Versus AI

| Holger Lange and Cris Luengo

Not only is artificial intelligence not intended to replace pathologists – at the moment, it can’t function without them!

Inside the Lab Clinical care

Leading the Pack

| Marisa Saint Martin

Pathologists hold the key to diagnostic management teams – and diagnostic management teams have a lot to contribute to patient care

Outside the Lab Biochemistry and molecular biology

Pre-Empting Relapse

| Luke Turner

A new DNA test that can detect treatment-resistant mutations could prove crucial for patients with acute myeloid leukemia, providing an early indication that targeted therapeutic intervention is needed

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register